KLRK1 and hepatocellular carcinoma: Nevertheless, NKG2D has been reported to promote HCC tumor growth in diethylnitrosamine induced HCC model (33), suggesting the determined NK cell-mediated anti-tumor effects via upregulated NKG2D ligands in our study.